New Therapy Strategy for Prostate Cancer: Amanita phalloides Treatment Stabilizes Best Without Pre-treatments (Observational Study Pre-protocol)

@inproceedings{Riede2017NewTS,
  title={New Therapy Strategy for Prostate Cancer: Amanita phalloides Treatment Stabilizes Best Without Pre-treatments (Observational Study Pre-protocol)},
  author={Isolde Riede},
  year={2017}
}
Background: Amanita phalloides (Amanita) contains amanitin, inhibiting RNA polymerase II. Partial inhibition with amanitin influences tumor cell but not normal cell activity. Patients treated with Amanita often gain a stable disease state without further tumor growth. Aim: Several therapies for prostate cancer are in use so far. This study evaluates the implementation of the Amanita therapy into the therapeutic regimen of today. Methods: 38 Patients with diagnosed prostate cancer were treated… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 12 REFERENCES

Endocrine prevention and treatment of prostate cancer

  • Molecular and Cellular Endocrinology
  • 2012
VIEW 1 EXCERPT

The role of hormonal treatment in prostate cancer.

  • Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
  • 2007
VIEW 1 EXCERPT

Toxins of Amanita phalloides.

  • Toxicon : official journal of the International Society on Toxinology
  • 1998
VIEW 1 EXCERPT